Balactual, Norhana .
HRN: 15-48-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
CO-AMOXICLAV 625MG (TAB)
09/27/2023
10/04/2023
PO
625kg
BID X 7 Days
S/P NSVD; PROM X 24 Hours
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes